The biomarker is used to determine the reactions of biological body fluids, cells, and tissues, using biochemical, immunological, genetic, and other methods to indicate the existence of pollutants and the reaction of biological individuals. Biomarkers can directly target cells or molecules in vivo as the reaction endpoint, which is very sensitive. The test results can show whether the cells and tissues in the biological individual have been exposed to excessive pollutants, whether the environmental pollutants have induced toxic effects on biological targets, and whether the toxic effects on populations, communities, or ecosystems have caused a chain reaction.
CD Mitochondria's bioanalysis team has excellent experience in the development, and validation of biomarker analysis methods. CD Mitochondria's biomarker analysis platform can be used for single-factor and multi-factor detection of a variety of biological substrates, verify the effectiveness of new biomarkers, and to monitor the activity of biomedicine by detecting therapeutic targets.
CD Mitochondria uses advanced proteomics technology to find relevant biomarkers in samples, SELDI-TOF-MS to screen biomarkers related to mitochondrial diseases, RP-HPLC to separate and purify samples, tracks target proteins with MALDI-TOF-MS, and identifies potential mitochondrial protein markers by LC-MS/MS.
CD Mitochondria always provides you with customized services for mitochondrial research, and our one-stop research and analysis platform can meet all your research needs.
CD Mitochondria has the most professional team to serve customers around the world. If you have any questions about the content of this service, please feel free to contact us. We look forward to your contact.